Common Contracts
2 similar Exclusive License Agreement contracts by Trevi Therapeutics, Inc.
Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT...Exclusive License Agreement • April 5th, 2019 • Trevi Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
For the sake of clarity, each Milestone Payment is payable no more than once and only with respect to the first achievement of the relevant Milestone Event for a Licensed Product. In no event shall all Milestone Payments, in the aggregate, total more than $62,500. In no event shall any Milestone Payment be payable after the end of the expiration of the last Valid Claim of the Patent Rights.
Confidential Materials omitted and filed with the Securities and Exchange Commission. Asterisks denote omissions. EXCLUSIVE LICENSE AGREEMENT BETWEEN RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY AND TREVI THERAPEUTICS, INC. EFFECTIVE NOVEMBER 6, 2018Exclusive License Agreement • November 19th, 2018 • Trevi Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
For the sake of clarity, each Milestone Payment is payable no more than once and only with respect to the first achievement of the relevant Milestone Event for a Licensed Product. In no event shall all Milestone Payments, in the aggregate, total more than $62,500. In no event shall any Milestone Payment be payable after the end of the expiration of the last Valid Claim of the Patent Rights.
